Suzetrigine: A New and Novel Analgesic for Acute Pain
Authors:
- Christopher DextrasCDChristopher Dextras
- Peggy ComptonPCPeggy Compton
Open Access
- 21 July 2026
- journal article
- Published by Elsevier in Pain Management Nursing
Abstract
No abstract availableFunding Information
- Rita and Alex Hillman Foundation (10087974)
- Rita and Alex Hillman Foundation (PC)
This publication has 28 references indexed in Scilit:
- Suzetrigine for Acute Pain in the Emergency Department: A First-in-Class NaV1.8 BlockerJACEP Open, 2026
- Suzetrigine: First ApprovalDrugs, 2025
- Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe PainPain and Therapy, 2025
- Efficacy of nonopioid analgesics and adjuvants in multimodal analgesia for reducing postoperative opioid consumption and complications in obesity: a systematic review and network meta-analysisBritish Journal of Anaesthesia, 2024
- Rational Multimodal Analgesia for Perioperative Pain ManagementCurrent Pain and Headache Reports, 2023
- Acute postoperative pain managementBritish Journal of Surgery, 2020
- Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative CouncilThe Journal of Pain, 2016
- The trafficking of NaV1.8Neuroscience Letters, 2010
- Cellular and Molecular Mechanisms of PainCell, 2009
- In the arms of morpheus: the development of morphine for postoperative pain reliefCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2000